Bionest

Increasing Role for Biomarkers in R&D, Clinical Medicine, and Pharma Marketing

Bionest team member Rachel Laing recently contributed to a feature in the January issue of PharmaVoice on the growing role and prominence of biomarker strategies in drug development and commercialization. In addition to helping to better identify those patients who will respond to a particular therapy, a biomarker strategy enables companies to differentiate their product and...

Bionest

Happy New Year! Here Are Three Key Areas to Watch in 2016

First of all, we at Bionest want to wish you a very happy, healthy, and prosperous new year.  And we look forward to speaking to many of you in person during JP Morgan week in San Francisco!   Another year ended. Another begun. In the time-honored tradition of year-end wrap-ups and new year’s predictions, we...